A decade of immune-checkpoint inhibitors in cancer therapy

Caroline Robert

View at source ↗PDF ↗Article1,607 citations

Abstract

Immunotherapy using immune-checkpoint modulators revolutionizes the oncology field far beyond their remarkable clinical efficacy in some patients. It creates radical changes in the evaluation of treatment efficacy and toxicity with a more holistic vision of the patient with cancer.

Abstract of "A decade of immune-checkpoint inhibitors in cancer therapy" by Caroline Robert, https://doi.org/10.1038/s41467-020-17670-y, used under its Creative Commons Attribution license (CC-BY); markup removed, otherwise unmodified.

Record

Archive ID
doi:10.1038/s41467-020-17670-y
Published
Jul 30, 2020
Venue
Nature Communications
DOI
10.1038/s41467-020-17670-y
PubMed
32732879
Categories
Cancer Immunotherapy and Biomarkers
License
cc-by
Provenance
openalex

Topics